Bolliger C T, Probst R, Tschopp K, Solèr M, Perruchoud A P
Department of Internal Medicine, University Hospital, Basel, Switzerland.
Chest. 1993 Dec;104(6):1653-9. doi: 10.1378/chest.104.6.1653.
Various stent models have been developed for the treatment of inoperable stenoses of the central airways caused by external compression. Increasing use is made of the silicone stents designed by Dumon. We tested their technical feasibility, tolerance, and long-term efficacy in relieving respiratory symptoms in patients referred for endoscopic palliation of malignant disease.
All procedures were performed under general anesthesia with the use of the rigid bronchoscope. We inserted 38 stents in 31 patients (median age, 67 years; 25 men and 6 women) whose airways showed residual obstruction of > 50 percent of the lumen after laser resection of endobronchial tumor and/or mechanical dilatation of extrinsic compressions.
Stent placement and removal--where necessary--were easy in all patients, but five stents inserted in three patients with short (< or = 2.5 cm) and conical stenoses migrated, necessitating emergency removal. In 27 of the remaining 28 patients, stent tolerance was excellent; 1 proximal tracheal stent (< 1 cm below the vocal cords) had to be removed because of otalgia and dysphagia. One lethal hemoptysis occurred within hours after a repeated laser therapy and removal of an indwelling stent. No other serious complications occurred. Immediate and lasting relief of dyspnea and improvement in performance status (Karnofsky scale, activity index) was achieved in 90 percent (28/31) of patients (p < 0.01). The influence of adjuvant radiotherapy on local tumor recurrence and survival was analyzed in a subgroup of ten patients with stage IIIB squamous cell carcinoma with comparable performance status. Five did not undergo adjuvant radiotherapy (group A) and five did (group B). In group A, four of five stents were occluded by tumor recurrence above or below the stent after a median follow-up of 2 months; in group B, zero of five were occluded (p < 0.05) after 4 months. Median survival was 4 months in group A and 6 months in group B; the difference did not reach significance.
The silicone stents designed by Dumon are easily inserted and removed; they are also well tolerated and very efficacious in relieving respiratory symptoms caused by extrinsic airway compression. Short and conical stenoses present limitations for their use due to increased risk of migration. Combined treatment with laser resection, stent insertion, and subsequent radiotherapy is necessary to prevent local tumor recurrence and may improve survival.
已开发出多种支架模型用于治疗由外部压迫导致的无法手术的中央气道狭窄。杜蒙设计的硅胶支架的使用越来越多。我们测试了其在因恶性疾病接受内镜姑息治疗的患者中缓解呼吸道症状的技术可行性、耐受性及长期疗效。
所有操作均在全身麻醉下使用硬支气管镜进行。我们为31例患者(中位年龄67岁;25例男性和6例女性)插入了38个支架,这些患者的气道在激光切除支气管内肿瘤和/或机械扩张外部压迫后显示管腔残余梗阻超过50%。
在所有患者中,支架的放置及必要时的取出都很容易,但3例患有短(≤2.5 cm)锥形狭窄的患者所插入的5个支架发生了移位,需要紧急取出。在其余28例患者中的27例,支架耐受性良好;1个位于气管近端(声带下方<1 cm处)的支架因耳痛和吞咽困难而不得不取出。1例患者在重复激光治疗并取出留置支架数小时内发生致命性咯血。未发生其他严重并发症。90%(28/31)的患者呼吸困难立即且持久缓解,身体状况(卡诺夫斯基量表、活动指数)得到改善(p<0.01)。在一个由10例具有可比身体状况的IIIB期鳞状细胞癌患者组成的亚组中,分析了辅助放疗对局部肿瘤复发和生存的影响。5例未接受辅助放疗(A组),5例接受了辅助放疗(B组)。在A组中,5个支架中的4个在中位随访2个月后被支架上方或下方的肿瘤复发阻塞;在B组中,5个支架中0个在4个月后被阻塞(p<0.05)。A组中位生存期为4个月,B组为6个月;差异无统计学意义。
杜蒙设计的硅胶支架易于插入和取出;它们耐受性良好,在缓解由外部气道压迫引起的呼吸道症状方面非常有效。短的锥形狭窄因其移位风险增加而在使用上存在局限性。联合激光切除、支架置入及后续放疗对于预防局部肿瘤复发是必要的,且可能改善生存。